Patents by Inventor James A. Landro

James A. Landro has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-APOC3 ANTIBODIES AND METHODS OF USE THEREOF
    Publication number: 20220025027
    Abstract: The instant disclosure provides antibodies that specifically bind to ApoC3 (e.g., human ApoC3) and antagonize ApoC3 function. Also provided are pharmaceutical compositions comprising these antibodies, nucleic acids encoding these antibodies, expression vectors and host cells for making these antibodies, and methods of treating a subject using these antibodies.
    Type: Application
    Filed: July 7, 2021
    Publication date: January 27, 2022
    Inventors: Paul DASILVA-JARDINE, Hans DE HAARD, James A. LANDRO
  • ANTI-APOC3 ANTIBODIES AND METHODS OF USE THEREOF
    Publication number: 20220025026
    Abstract: The instant disclosure provides antibodies that specifically bind to ApoC3 (e.g., human ApoC3) and antagonize ApoC3 function. Also provided are pharmaceutical compositions comprising these antibodies, nucleic acids encoding these antibodies, expression vectors and host cells for making these antibodies, and methods of treating a subject using these antibodies.
    Type: Application
    Filed: July 7, 2021
    Publication date: January 27, 2022
    Inventors: Paul DASILVA-JARDINE, Hans DE HAARD, James A. LANDRO
  • Anti-ApoC3 antibodies and methods of use thereof
    Patent number: 11091539
    Abstract: The instant disclosure provides antibodies that specifically bind to ApoC3 (e.g., human ApoC3) and antagonize ApoC3 function. Also provided are pharmaceutical compositions comprising these antibodies, nucleic acids encoding these antibodies, expression vectors and host cells for making these antibodies, and methods of treating a subject using these antibodies.
    Type: Grant
    Filed: January 7, 2019
    Date of Patent: August 17, 2021
    Assignee: STATEN BIOTECHNOLOGY B.V.
    Inventors: Paul DaSilva-Jardine, Hans de Haard, James A. Landro
  • ANTI-APOC3 ANTIBODIES AND METHODS OF USE THEREOF
    Publication number: 20190241648
    Abstract: The instant disclosure provides antibodies that specifically bind to ApoC3 (e.g., human ApoC3) and antagonize ApoC3 function. Also provided are pharmaceutical compositions comprising these antibodies, nucleic acids encoding these antibodies, expression vectors and host cells for making these antibodies, and methods of treating a subject using these antibodies.
    Type: Application
    Filed: January 7, 2019
    Publication date: August 8, 2019
    Inventors: Paul DaSilva-Jardine, Hans de Haard, James A. Landro
  • Methods for screening and identifying compounds
    Publication number: 20060068456
    Abstract: The present invention relates to methods for assessing enzyme activity utilizing a phase partition system. In addition, the present invention also relates to methods for screening and identifying compounds that may be used, for example, for the treatment of diabetes, diabetes-related disorders, obesity, cardiovascular disease, cancer, and other diseases or disorders, using this phase partition system.
    Type: Application
    Filed: November 2, 2005
    Publication date: March 30, 2006
    Applicant: Bayer Pharmaceuticals Corporation
    Inventors: James Landro, David Osterman, Walter Pickett
  • Method for assaying enzyme activity
    Patent number: 6994956
    Abstract: The present invention relates to methods for assessing enzyme activity utilizing a phase partition system. In addition, the present invention also relates to methods for screening and identifying compounds that may be used, for example, for the treatment of diabetes, diabetes-related disorders, obesity, cardiovascular disease, cancer, and other diseases or disorders, using this phase partition system.
    Type: Grant
    Filed: August 4, 2004
    Date of Patent: February 7, 2006
    Assignee: Bayer Pharmaceuticals Corporation
    Inventors: James A. Landro, David G. Osterman, Walter Pickett
  • Methods for screening and identifying compounds
    Publication number: 20050064531
    Abstract: The present invention relates to methods for assessing enzyme activity utilizing a phase partition system. In addition, the present invention also relates to methods for screening and identifying compounds that may be used, for example, for the treatment of diabetes, diabetes-related disorders, obesity, cardiovascular disease, cancer, and other diseases or disorders, using this phase partition system.
    Type: Application
    Filed: August 4, 2004
    Publication date: March 24, 2005
    Applicant: Bayer Pharmaceuticals Corporation
    Inventors: James Landro, David Osterman, Walter Pickett